TIBET PHARMA(SH:600211) Xin Lang Cai Jing·2025-09-04 05:32Group 1 - The core point of the news is that Xizang Pharmaceutical experienced a decline of 5.14% in its stock price, reaching 47.23 CNY per share, with a trading volume of 588 million CNY and a turnover rate of 3.75%, resulting in a total market capitalization of 15.223 billion CNY [1] - Xizang Pharmaceutical, established on July 14, 1999, and listed on July 21, 1999, is primarily engaged in pharmaceutical manufacturing, with 99.80% of its revenue coming from drug sales and 0.20% from other sources [1] Group 2 - Among the top circulating shareholders of Xizang Pharmaceutical, Huaxia Fund's Huaxia Industry Prosperity Mixed Fund (003567) held 1.9036 million shares in the second quarter, unchanged from the previous period, representing 0.59% of the circulating shares, with an estimated floating loss of approximately 4.8733 million CNY [2] - The Huaxia Industry Prosperity Mixed Fund, established on February 4, 2017, has a latest scale of 7.261 billion CNY, with a year-to-date return of 40.02%, ranking 1173 out of 8180 in its category, and a one-year return of 84.25%, ranking 619 out of 7978 [2]